Daum, A., Schlicker, L., Schneider, M., Muley, T., Klingmüller, U., Schulze, A., . . . Sültmann, H. (2025). Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis. Cancer & metabolism, 13, . https://doi.org/10.1186/s40170-025-00400-7
Chicago-Zitierstil (17. Ausg.)Daum, Ann-Kathrin, Lisa Schlicker, Marc Schneider, Thomas Muley, Ursula Klingmüller, Almut Schulze, Michael Thomas, Petros Christopoulos, und Holger Sültmann. "Cancer-associated Fibroblasts Promote Drug Resistance in ALK-driven Lung Adenocarcinoma Cells by Upregulating Lipid Biosynthesis." Cancer & Metabolism 13 (2025). https://doi.org/10.1186/s40170-025-00400-7.
MLA-Zitierstil (9. Ausg.)Daum, Ann-Kathrin, et al. "Cancer-associated Fibroblasts Promote Drug Resistance in ALK-driven Lung Adenocarcinoma Cells by Upregulating Lipid Biosynthesis." Cancer & Metabolism, vol. 13, 2025, https://doi.org/10.1186/s40170-025-00400-7.